Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype

Mansour Alfayez, Sa A. Wang, Sarah A. Bannon, Dimitrios P. Kontoyiannis, Steven M. Kornblau, Jordan S. Orange, Emily M. Mace, Courtney D. DiNardo

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Germline mutations in GATA2 are associated with a complex immunodeficiency and cancer predisposition syndrome. Somatic GATA2mut in myeloid malignancies may impart a similar phenotype. We reviewed adult patients with a diagnosis of GATA2mut hematological malignancy who were referred to our HHMC for genetic testing, and identified to have somatic GATA2mut. Nine patients with a median age of 63 years were included. Six patients (66.7%) were males. Atypical CML and acute myeloid leukemia were the most common initial presentation. The median overall VAF was 47.14%. Monocytopenia was pronounced when the GATA2mut involved the C-terminal ZFD. GATA2 N-terminal ZFD mutations tend to be co-mutated with biCEBPAmut. Unlike germline GATA2 mutations, monocytopenia associated with somatic GATA2 mutations often resolved at remission. We concluded that similar to germline GATA2 mutations, a subset of somatic GATA2 mutations can impart a germline phenotype.

Original languageEnglish (US)
Pages (from-to)2025-2033
Number of pages9
JournalLeukemia and Lymphoma
Volume60
Issue number8
DOIs
StatePublished - Jul 3 2019

Keywords

  • Emberger syndrome
  • GATA2
  • MonoMAC syndrome
  • immunodeficiency
  • pulmonary alveolar proteinosis

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype'. Together they form a unique fingerprint.

Cite this